Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02155491 · ClinicalTrials.gov registry record
Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events
A clinical trial of Pulmonary Embolism and Venous Thromboembolism, sponsored by Thrombosis Research Institute.
- Completed
- Registry status
- 10,679
- Enrollment target
- 1
- Study location
NCT02155491: Completed study of Pulmonary Embolism and Venous Thromboembolism, sponsored by Thrombosis Research Institute.
NCT02155491 is a study of Pulmonary Embolism and Venous Thromboembolism that has completed, run by Thrombosis Research Institute. The registered enrollment target is 10,679 participants, above the 2,836-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (277% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02155491, a study of Pulmonary Embolism and Venous Thromboembolism, has completed, sponsored by Thrombosis Research Institute.
- COMPLETED
- Registry status
- 10,679 participants
- Enrollment target
- 1
- Study location
Study Summary
The protocol is a large registry to describe acute, sub-acute and extended duration of anticoagulation management, clinical and economic duration of anticoagulation management, clinical and economic outcomes in patients with treated acute VTE (DVT and PE) in the real-world setting. Main objectives are to clarify the: * treatment related details for acute VTE (either conventional anticoagulation therapy, treatment with a direct oral anti-coagulant or other modalities of treatment) * Rate of early and late symptomatic VTE recurrence * Rate and nature of complications of VTE including post thrombotic syndrome and chronic thromboembolic pulmonary hypertension * Rate of bleeding complications * Rate of all-cause mortality at six months
Primary Outcome
Rate of recurrent symptomatic VTE (DVT and fatal or non-fatal PE)
Conditions Studied
Study Locations (1)
Alabama
- Dr Terence Hart - Muscle Shoals
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,679 participants |
| Start Date | 2014-07-07 |
| Est. Completion | 2020-09-30 |
What the finished NCT02155491 record still lists
NCT02155491 is an observational study that tracks outcomes without assigning an intervention. Its 10,679 participants enrollment target places it among the larger protocols in the corpus, above the 2,836-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (277% higher).
The record links to 3 conditions, with Pulmonary Embolism appearing as the primary indexed condition, and to 0 interventions.
NCT02155491 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT02155491 about?
NCT02155491 is a clinical study titled "Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events". The protocol is a large registry to describe acute, sub-acute and extended duration of anticoagulation management, clinical and economic duration of anticoagulation management, clinical and economic outcomes in patients with treated acute VTE (DVT and PE) in the real-world setting. Main objectives ...
What is the current status of trial NCT02155491?
This trial is currently completed. The enrollment target is 10,679 participants. The study started on 2014-07-07. Estimated completion is 2020-09-30.
What conditions does trial NCT02155491 study?
This clinical trial studies the following conditions: Pulmonary Embolism, Venous Thromboembolism, Deep Vein Thrombosis.
Who is sponsoring clinical trial NCT02155491?
This trial is sponsored by Thrombosis Research Institute, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02155491 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Embolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02155491's enrollment target sits among peer trials
10,679 3rd of 48 higher than 46 of 48 other Pulmonary Embolism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Embolism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Mobility Outcomes in Post-Pulmonary Embolic Disease
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
The PERSEVERE Study
RECRUITING · NA
-
Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
RECRUITING
-
Supplemental Oxygen in Pulmonary Embolism (SO-PE)
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06468202 · 10,742 participants · Phase 4
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
- NCT06081517 · 10,600 participants
Evaluating Disparities in Precision Oncology
- NCT05759299 · 10,500 participants
International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia
- NCT06891222 · 10,500 participants
A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI